Aprezo 30 mg: As A Phosphodiesterase 4 Inhibitor
Created 1 week ago by marykudro

Aprezo 30 mg specifically contains Apremilast which falls under the group of medications known as phosphodiesterase 4 inhibitors. The aprezo 30 mg is used for the treatment of adult patients with active psoriatic arthritis, moderate/severe chronic plaque psoriasis, and Behcet’s disease (BD). Psoriatic arthritis specifically is an inflammatory disease of the joint mainly affects individuals with psoriasis which is an inflammatory disease condition of the skin. Plaque psoriasis is mainly characterized by red, scaly, itchy, thick, painful patches on the skin and affects the scalp as well as nails. Behcet’s disease is a rare inflammatory disease that affects multiple parts of the body.

https://www.ikrispharmanetwork.com/apremilast-otezla/